期刊文献+

戈谢病GBA基因突变致血小板输注无效1例 被引量:2

Platelet transfusion refractoriness caused by GBA gene mutation in one patient with Gaucher disease
下载PDF
导出
摘要 目的分析1例血小板输注无效患者及其家系戈谢病葡萄糖脑苷脂酶(GBA)基因突变特征。方法 1例贫血及血小板减少的女性患者经血小板输注无效后,对其进行骨髓细胞学、B超及基因测序检测;采用干血斑法检测其白细胞β-葡糖脑苷脂酶活性;提取该家系8个成员(包括先证者及其直系亲属)外周血基因组DNA进行基因测序。结果骨髓细胞学检查示该例患者可见戈谢细胞(6.0%),白细胞β-葡糖脑苷脂酶活性为3.78 nmol/(h·mgPro),B超结果示脾肿大;基因测序分析发现其为GBA基因c.484A>G纯合错义突变;家系调查结果表明,先证者父母、子女及妹妹5人均为GBA基因杂合突变。结论戈谢病患者可因脾功能亢进而出现血小板输注无效;GBA基因突变为该家系的主要致病因素。 Objective To analyze the mutation characteristics of GBA gene in one patient with Gaucher disease and platelet transfusion refractoriness. Methods A female patient with anemia and thrombocytopenia showed platelet transfusion refractoriness, and then the proband and her family were performed bone marrow smear, β-glucocerebrosidase activity in leukocytes ( dried blood spot assay), β- ultrasonography and gene sequencing examination and pedigree investigation. Results Pedigree investigation showed that the heterozy- gous mutation of GBA gene existed in the father, mother, son, daughter and sister of the proband. Bone marrow cytomorphologic exami- nation showed that Gaucher cells accounted for 6.0% in the female patient. The β-glucocerebrosidase activity in leukocytes was 3.78 nmol/(h · mg Pro). B-ultrasonography showed slightly splenomegaty. Gene sequencing found that the homozygous mutation of GBA gene, c. 484A 〉 G, existed in the female patient. Conclusion The patients with Gaucher disease may appear platelet transfusion re- fractoriness due to hypersplenism. The mutation of GBA gene is the main pathogenic factor of the family with Gancher disease.
出处 《临床检验杂志》 CAS CSCD 2017年第5期330-333,共4页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金(81660144)
关键词 血小板输注无效 戈谢病 葡萄糖苷酯酶基因突变 platelet transfusion refractoriness Gaucher disease GBA gene mutation
  • 相关文献

参考文献4

二级参考文献72

  • 1段彦龙,张永红,臧晏,施惠平,张为民,胡亚美.酶替代治疗戈谢病72例[J].中华儿科杂志,2006,44(9):653-656. 被引量:35
  • 2Beufler E, Gradowski OK. Gaucher disease [M]//Seriver CR, Beaudet A, Sly WS, et al. The metabolic and molecular bases of inherited disease. 8e eds. New York: MeGraw. Hil. 2001.
  • 3Charrow J, Andersson HC, Kaplan P, et al. The Gaucher registry., demographics and disease characteristics of 1698 patients with Gaucher disease [J]. Arch Intern Med, 2000, 160(18).. 2835-2843.
  • 4Koprivica V, Stone DL, Park JK, et aL Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease [J]. Am J Hum Genet, 2000, 66(6): 1777-1786.
  • 5Kim JW, Liou BB, Lai MY, et al. Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwan Residents) populations [J]. Hum Mutat, 1996, 7(3): 214-218.
  • 6Pastores GM, Hughes DA. Gaucher Disease [M/OL]//Pa- gon RA, Bird TC, Dolan CR, et aL GeneReviews. http: //www.ncbi.nlm.nih.gov/books/.
  • 7Park J-K, Orvisky E, Tayebi N, et al. Myoclonic epilepsy in gaucher disease: genotype-phenotype insights from a rare patient subgroup[J].PediatrRes, 2003, 53(3): 387-395.
  • 8Manganotfi P, Tamburin S, Zanette G, et aL Hyperexcit- able cortical responses in progressive myoclonic epilepsy: aTMS study [J]. Neurology, 2001, 57(10). 1793-1799.
  • 9Abrahamov A, Elstein D, Horowitz M, et al. A new Gaucher disease variant characterized by progressive calci- fication of heart valves and unique genotype [J]. Lancet, 1995, 346(8981): 1000-1003.
  • 10Elstein D, Zimran A. Review of the safety and efficacy of imiglucerase treatment of Gaucher disease [J]. Biologics, 2009, 3: 407-417.

共引文献10

同被引文献5

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部